177 related articles for article (PubMed ID: 23165940)
21. Mucin biosynthesis: epidermal growth factor downregulates core 2 enzymes in a human airway adenocarcinoma cell line.
Beum PV; Bastola DR; Cheng PW
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):48-56. PubMed ID: 12600830
[TBL] [Abstract][Full Text] [Related]
22. A glycosyltransferase-enriched reconstituted membrane system for the synthesis of branched O-linked glycans in vitro.
Susini S; Jeanneau C; Mathieu S; Carmona S; El-Battari A
Biochim Biophys Acta; 2011 Jun; 1808(6):1509-19. PubMed ID: 21081110
[TBL] [Abstract][Full Text] [Related]
23. Functional genomics identifies N-acetyllactosamine extension of complex N-glycans as a mechanism to evade lysis by natural killer cells.
Zhuang X; Woods J; Ji Y; Scheich S; Mo F; Rajagopalan S; Coulibaly ZA; Voss M; Urlaub H; Staudt LM; Pan KT; Long EO
Cell Rep; 2024 Apr; 43(4):114105. PubMed ID: 38619967
[TBL] [Abstract][Full Text] [Related]
24. Study of the biological functions of mucin type core 3 O-glycans.
Lee SH; Fukuda M
Methods Mol Biol; 2013; 1022():41-50. PubMed ID: 23765652
[TBL] [Abstract][Full Text] [Related]
25. Increased expression of GCNT1 is associated with altered O-glycosylation of PSA, PAP, and MUC1 in human prostate cancers.
Chen Z; Gulzar ZG; St Hill CA; Walcheck B; Brooks JD
Prostate; 2014 Jul; 74(10):1059-67. PubMed ID: 24854630
[TBL] [Abstract][Full Text] [Related]
26. Roles of mucin-type O-glycans in cell adhesion.
Fukuda M
Biochim Biophys Acta; 2002 Dec; 1573(3):394-405. PubMed ID: 12417424
[TBL] [Abstract][Full Text] [Related]
27. Haploinsufficiency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death.
Cabrera PV; Amano M; Mitoma J; Chan J; Said J; Fukuda M; Baum LG
Blood; 2006 Oct; 108(7):2399-406. PubMed ID: 16778138
[TBL] [Abstract][Full Text] [Related]
28. Core3 glycan as tumor suppressor.
Lee SH; Fukuda M
Methods Enzymol; 2010; 479():143-54. PubMed ID: 20816164
[TBL] [Abstract][Full Text] [Related]
29. CD45 modulates galectin-1-induced T cell death: regulation by expression of core 2 O-glycans.
Nguyen JT; Evans DP; Galvan M; Pace KE; Leitenberg D; Bui TN; Baum LG
J Immunol; 2001 Nov; 167(10):5697-707. PubMed ID: 11698442
[TBL] [Abstract][Full Text] [Related]
30. Site directed processing: role of amino acid sequences and glycosylation of acceptor glycopeptides in the assembly of extended mucin type O-glycan core 2.
Brockhausen I; Dowler T; Paulsen H
Biochim Biophys Acta; 2009 Oct; 1790(10):1244-57. PubMed ID: 19524017
[TBL] [Abstract][Full Text] [Related]
31. In vivo overexpression of Core2 N-acetylglucosaminyltransferase prevents repopulation of the bone marrow with colony forming cells but fails to affect normal T cell development.
Fellinger WJ; Barran P; Merkens H; Corbel SY; Ziltener HJ
J Cell Physiol; 1998 Aug; 176(2):350-8. PubMed ID: 9648922
[TBL] [Abstract][Full Text] [Related]
32. O-glycans on death receptors in cells modulate their sensitivity to TRAIL-induced apoptosis through affecting on their stability and oligomerization.
Jiang Y; Wen T; Yan R; Kim SR; Stowell SR; Wang W; Wang Y; An G; Cummings RD; Ju T
FASEB J; 2020 Sep; 34(9):11786-11801. PubMed ID: 32692906
[TBL] [Abstract][Full Text] [Related]
33. Poly-N-acetyllactosamine extension in N-glycans and core 2- and core 4-branched O-glycans is differentially controlled by i-extension enzyme and different members of the beta 1,4-galactosyltransferase gene family.
Ujita M; Misra AK; McAuliffe J; Hindsgaul O; Fukuda M
J Biol Chem; 2000 May; 275(21):15868-75. PubMed ID: 10747980
[TBL] [Abstract][Full Text] [Related]
34. Expression of stable human O-glycan core 2 beta-1,6-N-acetylglucosaminyltransferase in Sf9 insect cells.
Toki D; Sarkar M; Yip B; Reck F; Joziasse D; Fukuda M; Schachter H; Brockhausen I
Biochem J; 1997 Jul; 325 ( Pt 1)(Pt 1):63-9. PubMed ID: 9224630
[TBL] [Abstract][Full Text] [Related]
35. Requirement for core 2 O-glycans for optimal resistance to helminth infection.
Mullaly SC; Oudhoff MJ; Min PH; Burrows K; Antignano F; Rattray DG; Chenery A; McNagny KM; Ziltener HJ; Zaph C
PLoS One; 2013; 8(3):e60124. PubMed ID: 23555902
[TBL] [Abstract][Full Text] [Related]
36. POMGNT1 Is Glycosylated by Mucin-Type O-Glycans.
Xin X; Akasaka-Manya K; Manya H; Furukawa J; Kuwahara N; Okada K; Tsumoto H; Higashi N; Kato R; Shinohara Y; Irimura T; Endo T
Biol Pharm Bull; 2015; 38(9):1389-94. PubMed ID: 26328495
[TBL] [Abstract][Full Text] [Related]
37. Glycosyltransferase function in core 2-type protein O glycosylation.
Stone EL; Ismail MN; Lee SH; Luu Y; Ramirez K; Haslam SM; Ho SB; Dell A; Fukuda M; Marth JD
Mol Cell Biol; 2009 Jul; 29(13):3770-82. PubMed ID: 19349303
[TBL] [Abstract][Full Text] [Related]
38. Selenium-containing ruthenium complex synergizes with natural killer cells to enhance immunotherapy against prostate cancer via activating TRAIL/FasL signaling.
Lai H; Zeng D; Liu C; Zhang Q; Wang X; Chen T
Biomaterials; 2019 Oct; 219():119377. PubMed ID: 31374478
[TBL] [Abstract][Full Text] [Related]
39. Restricted processing of CD16a/Fc γ receptor IIIa
Patel KR; Roberts JT; Subedi GP; Barb AW
J Biol Chem; 2018 Mar; 293(10):3477-3489. PubMed ID: 29330305
[TBL] [Abstract][Full Text] [Related]
40. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
Valenzuela HF; Pace KE; Cabrera PV; White R; Porvari K; Kaija H; Vihko P; Baum LG
Cancer Res; 2007 Jul; 67(13):6155-62. PubMed ID: 17616672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
